Rare variants in non-coding regulatory regions of the genome that affect gene expression in systemic lupus erythematosus

Autor: Ina Rudloff, Stefan J. White, Stuart Cantsilieris, Wendy Dankers, Melissa Northcott, Elena J. Tucker, James Harris, Qiang Cheng, Eric F Morand, Brendan E. Russ, Marcel F. Nold, Andrew E. J. Toh, Huapeng Fan, Sarah A. Jones
Přispěvatelé: Clinical Immunology and Rheumatology
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
Linkage disequilibrium
lcsh:Medicine
Locus (genetics)
Single-nucleotide polymorphism
Genome-wide association study
Regulatory Sequences
Nucleic Acid

Biology
Polymorphism
Single Nucleotide

Genome
Linkage Disequilibrium
Article
03 medical and health sciences
Systemic lupus erythematosus
0302 clinical medicine
Genetics research
medicine
Humans
Lupus Erythematosus
Systemic

SNP
Genetic Predisposition to Disease
Polymorphism
lcsh:Science
skin and connective tissue diseases
030203 arthritis & rheumatology
Genetics
Multidisciplinary
Lupus erythematosus
Lupus Erythematosus
Nucleic Acid
business.industry
lcsh:R
Single Nucleotide
Lupus Erythematosus
Systemic/genetics

medicine.disease
Systemic/genetics
030104 developmental biology
lcsh:Q
Female
Personalized medicine
business
Regulatory Sequences
Genome-Wide Association Study
Zdroj: Scientific Reports
Scientific reports, 9(1). Nature Publishing Group
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
ISSN: 2045-2322
Popis: Personalized medicine approaches are increasingly sought for diseases with a heritable component. Systemic lupus erythematosus (SLE) is the prototypic autoimmune disease resulting from loss of immunologic tolerance, but the genetic basis of SLE remains incompletely understood. Genome wide association studies (GWAS) identify regions associated with disease, based on common single nucleotide polymorphisms (SNPs) within them, but these SNPs may simply be markers in linkage disequilibrium with other, causative mutations. Here we use an hierarchical screening approach for prediction and testing of true functional variants within regions identified in GWAS; this involved bioinformatic identification of putative regulatory elements within close proximity to SLE SNPs, screening those regions for potentially causative mutations by high resolution melt analysis, and functional validation using reporter assays. Using this approach, we screened 15 SLE associated loci in 143 SLE patients, identifying 7 new variants including 5 SNPs and 2 insertions. Reporter assays revealed that the 5 SNPs were functional, altering enhancer activity. One novel variant was linked to the relatively well characterized rs9888739 SNP at the ITGAM locus, and may explain some of the SLE heritability at this site. Our study demonstrates that non-coding regulatory elements can contain private sequence variants affecting gene expression, which may explain part of the heritability of SLE.
Databáze: OpenAIRE